Location History:
- Jarvso, SE (1996)
- 37 Hassleholm, SE (2001)
- Uppsala, SE (2023 - 2024)
Company Filing History:
3 out of 10 
2 out of 832,912 Years Active: 1996-2024
Title: Lars Boukharta Persson: Innovator in Phosphatidylinositol Phosphate Kinase Inhibitors
Introduction
Lars Boukharta Persson is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for phosphatidylinositol phosphate kinases. With a total of 5 patents to his name, his work is pivotal in addressing various health challenges.
Latest Patents
Among his latest patents, Lars has developed aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors. This invention relates to inhibitors of PI5P4K, which are useful in the treatment of cancers, neurodegenerative diseases, inflammatory disorders, and metabolic diseases. Another significant patent involves aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors, which also target similar health issues.
Career Highlights
Lars has worked with Hibercell, Inc., where he has applied his expertise in developing innovative solutions for complex medical conditions. His work has been instrumental in advancing therapeutic options for patients suffering from various diseases.
Collaborations
Lars has collaborated with notable professionals in his field, including Johan Lindström and Jenny Viklund. These partnerships have enhanced the scope and impact of his research.
Conclusion
Lars Boukharta Persson is a distinguished inventor whose work in phosphatidylinositol phosphate kinase inhibitors is making a significant impact in the medical field. His contributions are paving the way for new treatments and improving patient outcomes.